Aimco Pesticides (524288)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹97.8 |
| Market Cap | ₹93.72 Cr |
| P/E Ratio | 0 |
| ROCE | -12.42% |
| ROE | -40.65% |
| Dividend Yield | 0% |
| Profit Growth | -586.54% |
| Debt/Equity | — |
| Sales Growth | -40.3% |
| 52-Week Range | ₹36 — ₹97.8 |
| Sector | Fertilizers & Agrochemicals |
| Book Value | ₹33.51 |
Strengths
- Positive book value of ₹33.51 per share provides an asset cushion despite losses.
- Quarterly revenue of ₹30 Cr implies annualised revenue around ₹120 Cr, above the current market cap of ₹94 Cr.
- The company operates in essential agrochemicals/pesticides relevant to Indian agriculture.
- The stock is trading at its 52-week high, suggesting some market expectation of recovery.
Concerns
- Negative profitability: ROE is -40.65%, ROCE is -12.42%, and the latest quarter had a net loss of ₹3 Cr.
- Sharp operational deterioration: sales are down 40.30% and profit growth is -586.54%.
- Valuation is not supportive: P/B is 2.92, P/E is meaningless due to negative earnings, and there is no dividend yield.
- Piotroski F-Score of 2/9, with missing debt/equity and promoter-holding data, raises financial health and transparency concerns.
AI Analysis
At first glance, I like businesses that are simple and essential, and agrochemicals are necessary for Indian farms. But for Aimco Pesticides, the numbers do not support optimism. The stock trades at ₹97.80, near its 52-week high, yet book value is only ₹33.51. That means I'm paying 2.92 times book for a business earning -40.65% return on equity and -12.42% on capital. In the latest quarter, revenues were ₹30 Cr, but the company lost ₹3 Cr. Sales have fallen 40.30%, and profit growth has collapsed by 586.54%. When a company's profitability is negative, the P/E becomes meaningless; the figure of zero tells me there is no earnings base to judge. This is a 2/9 Piotroski F-score company, which is a red flag for financial health. There is no dividend while I wait. I can calculate that annualised sales of roughly ₹120 Cr are more than the ₹94 Cr market cap, so future recovery is possible only if margins return. But Ben Graham's first rule is not to lose money. Paying a premium over a beaten-up balance sheet with negative returns is not a margin of safety. I would need evidence that sales are stabilising, costs are under control, and returns are turning positive. Given no promoter-holding data and no debt/equity detail, I cannot fully assess governance or leverage. A stock can rise for many temporary reasons; value is built on durable earnings. At this price, Aimco Pesticides is a pass for me. I will keep it on the watchlist and wait for either a much lower price or clear fundamental improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer